Login / Signup

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial.

Ramavath D NaikVishnubhatla SreenivasVishwajeet SinghAshwati S PillaiDeepa DhawanSameer Bakhshi
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)
Olanzapine significantly improved CR rates for vomiting in children receiving the first cycle of HEC.
Keyphrases
  • chemotherapy induced
  • open label
  • phase iii
  • phase ii
  • clinical trial
  • study protocol
  • phase ii study
  • double blind
  • placebo controlled
  • young adults
  • randomized controlled trial
  • radiation therapy
  • locally advanced